Silo Pharma Announces Uplisting to Nasdaq Capital Market and Pricing of $5 Million Public Offering of Common Stock
September 27, 2022 09:05 ET
|
Silo Pharma, Inc.
ENGLEWOOD CLIFFS, NJ , Sept. 27, 2022 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (formerly OTCQB: SILO), a developmental stage biopharmaceutical company focused on merging traditional...
Correlate Infrastructure Partners Inc. Announces Its Application to Uplist to the NASDAQ Exchange
June 01, 2022 08:30 ET
|
Correlate Infrastructure Partners, Inc.
BOISE, Idaho, June 01, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- Correlate Infrastructure Partners Inc. (OTCQB: CIPI) (“Correlate” or the “Company”), a technology-enabled energy optimization and...
Worksport Announces Nasdaq Uplisting in Connection with Public Offering
August 04, 2021 08:00 ET
|
Worksport Ltd
Vaughan, Aug. 04, 2021 (GLOBE NEWSWIRE) -- Worksport Ltd. (Nasdaq-CM: WKSP; WKSPW) (or the “Company”), a developer and manufacturer of high quality, modular, and attractively priced tonneau covers,...
Protagenic Therapeutics, Inc. Announces Nasdaq Uplisting and Pricing of $13.2 Million Public Offering
April 26, 2021 20:58 ET
|
Protagenic Therapeutics, Inc.
New York, April 26, 2021 (GLOBE NEWSWIRE) -- Protagenic Therapeutics, Inc. (NASDAQ:PTIX) ("PTIX" or "Company") today announced the pricing of an underwritten public offering of 3,180,000 units at a...